CME Group Now Rated a “Buy” at UBS (CME)

Comment

Shutterstock photo

Futures exchange operator CME Group Inc. ( CME ) on Friday saw its rating and price target boosted by analysts at UBS.

The firm said it upgraded CME from "Neutral" to "Buy" with a $318 price target. That target suggests a 20% upside to the stock's Thursday closing price of $266.25.

Analysts at UBS noted the company has both cyclical and secular growth potential.

CME shares rose $3.75, or +1.4%, in premarket trading Friday.

The Bottom Line
Shares of CME Group ( CME ) have a 2.10% dividend yield, based on last night's closing stock price of $266.25. The stock has technical support in the $250-$260 price area. If the shares can firm up, we see overhead resistance around the $280 price level.

CME Group Inc. ( CME ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Created by Dividend.com



This article appears in: Investing , Stocks


More from Dividend.com







Dividend.com
Contributor:

Dividend.com

Dividends
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com